Nikolai I Kolodkin
Overview
Explore the profile of Nikolai I Kolodkin including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
6
Citations
265
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Agalakova N, Kolodkin N, Adair C, Trashkov A, Bagrov A
Int J Mol Sci
. 2021 Mar;
22(4).
PMID: 33669287
Despite prophylaxis and attempts to select a therapy, the frequency of preeclampsia does not decrease and it still takes the leading position in the structure of maternal mortality and morbidity...
2.
Fedorova O, Fadeev A, Grigorova Y, Marshall C, Zernetkina V, Kolodkin N, et al.
J Cardiovasc Pharmacol
. 2019 Aug;
74(5):436-442.
PMID: 31415452
Endogenous cardiotonic steroid, marinobufagenin (MBG), induces Fli1-dependent tissue fibrosis. We hypothesized that an increase in MBG initiates the development of aortic fibrosis in salt-loaded rats with type 2 diabetes mellitus...
3.
Antibody to Marinobufagenin Reverses Placenta-Induced Fibrosis of Umbilical Arteries in Preeclampsia
Fedorova O, Ishkaraeva V, Grigorova Y, Reznik V, Kolodkin N, Zazerskaya I, et al.
Int J Mol Sci
. 2018 Aug;
19(8).
PMID: 30104471
Background: Previous studies implicated cardiotonic steroids, including Na/K-ATPase inhibitor marinobufagenin (MBG), in the pathogenesis of preeclampsia (PE). Immunoneutralization of heightened MBG by Digibind, a digoxin antibody, reduces blood pressure (BP)...
4.
Fedorova O, Simbirtsev A, Kolodkin N, Kotov A, Agalakova N, Kashkin V, et al.
J Hypertens
. 2008 Nov;
26(12):2414-25.
PMID: 19008721
Background: Levels of marinobufagenin (MBG), an endogenous bufadienolide Na/K-ATPase (NKA) inhibitor, increase in preeclampsia and in NaCl-sensitive hypertension. Methods: We tested a 3E9 monoclonal anti-MBG antibody (mAb) for the ability...
5.
Kennedy D, Vetteth S, Periyasamy S, Kanj M, Fedorova L, Khouri S, et al.
Hypertension
. 2006 Feb;
47(3):488-95.
PMID: 16446397
Patients with chronic renal failure develop a "uremic" cardiomyopathy characterized by diastolic dysfunction, cardiac hypertrophy, and systemic oxidant stress. Patients with chronic renal failure are also known to have increases...
6.
Fedorova O, Kolodkin N, Agalakova N, Namikas A, Bzhelyansky A, St-Louis J, et al.
J Hypertens
. 2005 Mar;
23(4):835-42.
PMID: 15775789
Objective: The pathogenesis of pre-eclampsia (PE), a major cause of maternal and fetal mortality, is not fully understood. Digitalis-like sodium pump ligands (SPLs) are believed to be implicated in PE,...